TAZVERIK FDA approval date

The FDA approved TAZVERIK on 23 Jan 2020.

FDA approval date
23 Jan 2020

Drug identity has not yet been verified against registry records

Also recorded as TAZEMETOSTAT HYDROBROMIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2020-01-23DayTAZVERIKFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA211723", "applicant_as_listed_by_fda": "EPIZYME INC", "brand_names": ["TAZVERIK"], "active_ingredients": ["TAZEMETOSTAT HYDROBROMIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20200123", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026